AI Drug Discovery Company
Tinaclon, the essential particle for bio-pharma
The particle (on) that joins computing (Ti) and life (Na·Cl).Tinaclon builds easy, fast and effective drug discovery solutions.
Products
TRION, the drug discovery AI platform
Two products for different research needs.Desktop runs on your own PC, and Cloud scales up in the browser.
TRION Desktop
Free · runs on your computer
Run without limits on your own PC, with data that never leaves it.
Key features
- Structure review and GNINA docking
- Compound generation with REINVENT 4
- R-group enumeration and self design
- Runs on macOS and Windows
TRION Cloud
Pay as you go · runs in the browser
Runs in the browser with no install, and scales to tens of thousands of compounds.
Key features
- Virtual screening (GNINA)
- AI co-folding (Boltz-2)
- Target-specific activity prediction (TSAP)
- 500 free credits at sign-up
Core technology · TSAP
Activity prediction tuned to your target
Models trained on a single target's activity data predict compound activity and show which interactions drive it.
See why it predicts
Every prediction shows each interaction feature's contribution.
Target models, ready to run
Pretrained models for CBLB, EGFR and more, with validation results.
Train on your own data
Build a model for your target from your own activity data.
Why Tinaclon
Proven technology, designed for researchers
Built on peer-reviewed engines, so you can compute without worrying about your data or your budget.
21min
Docking 10,000 compounds on TRION Cloud
1/10
Compute cost versus traditional HPC
8 models
TSAP target models with validation results
Peer-reviewed engines
Reproducible results built on GNINA, Boltz-2 and REINVENT 4.
Data stays on your PC
Desktop computes on your own PC and never sends research data out.
Pay only for what you run
No infrastructure to build. Pay just for the compute you use.
Latest News
News from Tinaclon
Take the next step in drug discovery with Tinaclon.
Start with TRION today, or reach out about adoption and research partnerships.